Percent of Notified RR/MDR-TB Cases with DST Results for Second-line TB Drugs

References in the content below refer to the PBMEF Guide.

Definitions

Percentage of laboratory-confirmed pulmonary RR-TB/MDR-TB cases tested for susceptibility to second-line TB drugs (fluoroquinolones) among lab-confirmed pulmonary RR-TB/MDR- TB notified cases during the reporting period.

Numerator

Number of new or previously treated bacteriologically confirmed pulmonary TB patients with resistance to rifampicin and with test results for any fluoroquinolones during reporting period. WHO database: rr_dst_rlt_fq

Denominator

Number of new or previously treated bacteriologically confirmed pulmonary RR-TB/MDR-TB notified cases during the reporting period. WHO database: rr_new PLUS rr_ret

Ref #

RN-3

Tier Level

Extended Indicator

Data Type

Percentage

Disaggregations

N/A
There are no related indicators for this indicator.

Indicator Visualizations

We do not currently have an indicator visualization for this indicator. Please check back later.